US Stock MarketDetailed Quotes

PDS Biotechnology (PDSB)

Watchlist
  • 1.330
  • +0.230+20.91%
Close May 13 16:00 ET
  • 1.337
  • +0.007+0.50%
Pre 04:17 ET
74.23MMarket Cap-2.02P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

PDS Biotechnology (PDSB) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-28.39%6.52M
-13.15%31.54M
-9.32%6.67M
-20.03%8.14M
-12.22%7.62M
-9.82%9.11M
-15.62%36.32M
-29.27%7.36M
-3.24%10.18M
-31.60%8.68M
Selling and administrative expenses
-6.43%3.06M
-9.00%12.52M
-19.84%2.27M
5.60%3.56M
-17.95%3.41M
-3.50%3.27M
-9.99%13.76M
-3.75%2.83M
-17.10%3.37M
-11.40%4.16M
-General and administrative expense
-6.43%3.06M
-9.00%12.52M
-19.84%2.27M
5.60%3.56M
-17.95%3.41M
-3.50%3.27M
-9.99%13.76M
-3.75%2.83M
-17.10%3.37M
-11.40%4.16M
Research and development costs
-40.71%3.46M
-15.69%19.03M
-2.74%4.41M
-32.74%4.58M
-6.95%4.21M
-13.02%5.83M
-18.72%22.57M
-39.33%4.53M
5.51%6.8M
-43.44%4.53M
Operating profit
28.39%-6.52M
13.15%-31.54M
9.32%-6.67M
20.03%-8.14M
12.22%-7.62M
9.82%-9.11M
15.62%-36.32M
29.27%-7.36M
3.24%-10.18M
31.60%-8.68M
Net non-operating interest income expense
-49.72%-827.97K
-90.95%-4.12M
-50.09%-888.21K
-58.64%-869.27K
-253.16%-1.81M
-9.33%-553.03K
-65.65%-2.16M
-20.46%-591.78K
-66.31%-547.96K
-109.51%-512.76K
Non-operating interest income
-50.56%186.81K
-51.60%1.22M
-55.42%224.66K
-57.84%281.11K
-50.59%333.62K
-43.51%377.85K
-13.37%2.51M
-26.27%503.94K
-9.82%666.77K
-10.05%675.21K
Non-operating interest expense
9.01%1.01M
14.24%5.34M
1.56%1.11M
-5.30%1.15M
80.52%2.14M
-20.76%930.88K
11.11%4.67M
-6.73%1.1M
13.64%1.21M
19.35%1.19M
Other net income (expense)
Income before tax
23.91%-7.35M
7.31%-35.67M
4.90%-7.56M
16.01%-9.01M
-2.58%-9.43M
8.91%-9.66M
13.23%-38.48M
27.03%-7.95M
1.13%-10.73M
28.93%-9.2M
Income tax
0
-34.59%-1.17M
0
0
0
-1.17M
38.18%-869.17K
0
0
38.18%-869.17K
Net income
13.43%-7.35M
8.28%-34.5M
4.90%-7.56M
16.01%-9.01M
-13.28%-9.43M
19.94%-8.49M
12.42%-37.61M
27.03%-7.95M
1.13%-10.73M
27.80%-8.33M
Net income continuous Operations
13.43%-7.35M
8.28%-34.5M
4.90%-7.56M
16.01%-9.01M
-13.28%-9.43M
19.94%-8.49M
12.42%-37.61M
27.03%-7.95M
1.13%-10.73M
27.80%-8.33M
Minority interest income
Net income attributable to the parent company
13.43%-7.35M
8.28%-34.5M
4.90%-7.56M
16.01%-9.01M
-13.28%-9.43M
19.94%-8.49M
12.42%-37.61M
27.03%-7.95M
1.13%-10.73M
27.80%-8.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
13.43%-7.35M
8.28%-34.5M
4.90%-7.56M
16.01%-9.01M
-13.28%-9.43M
19.94%-8.49M
12.42%-37.61M
27.03%-7.95M
1.13%-10.73M
27.80%-8.33M
Basic earnings per share
38.10%-0.13
28.16%-0.74
33.33%-0.14
34.48%-0.19
8.70%-0.21
30.00%-0.21
25.90%-1.03
40.00%-0.21
17.14%-0.29
37.84%-0.23
Diluted earnings per share
38.10%-0.13
28.16%-0.74
33.33%-0.14
34.48%-0.19
8.70%-0.21
30.00%-0.21
25.90%-1.03
40.00%-0.21
17.14%-0.29
37.84%-0.23
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -28.39%6.52M-13.15%31.54M-9.32%6.67M-20.03%8.14M-12.22%7.62M-9.82%9.11M-15.62%36.32M-29.27%7.36M-3.24%10.18M-31.60%8.68M
Selling and administrative expenses -6.43%3.06M-9.00%12.52M-19.84%2.27M5.60%3.56M-17.95%3.41M-3.50%3.27M-9.99%13.76M-3.75%2.83M-17.10%3.37M-11.40%4.16M
-General and administrative expense -6.43%3.06M-9.00%12.52M-19.84%2.27M5.60%3.56M-17.95%3.41M-3.50%3.27M-9.99%13.76M-3.75%2.83M-17.10%3.37M-11.40%4.16M
Research and development costs -40.71%3.46M-15.69%19.03M-2.74%4.41M-32.74%4.58M-6.95%4.21M-13.02%5.83M-18.72%22.57M-39.33%4.53M5.51%6.8M-43.44%4.53M
Operating profit 28.39%-6.52M13.15%-31.54M9.32%-6.67M20.03%-8.14M12.22%-7.62M9.82%-9.11M15.62%-36.32M29.27%-7.36M3.24%-10.18M31.60%-8.68M
Net non-operating interest income expense -49.72%-827.97K-90.95%-4.12M-50.09%-888.21K-58.64%-869.27K-253.16%-1.81M-9.33%-553.03K-65.65%-2.16M-20.46%-591.78K-66.31%-547.96K-109.51%-512.76K
Non-operating interest income -50.56%186.81K-51.60%1.22M-55.42%224.66K-57.84%281.11K-50.59%333.62K-43.51%377.85K-13.37%2.51M-26.27%503.94K-9.82%666.77K-10.05%675.21K
Non-operating interest expense 9.01%1.01M14.24%5.34M1.56%1.11M-5.30%1.15M80.52%2.14M-20.76%930.88K11.11%4.67M-6.73%1.1M13.64%1.21M19.35%1.19M
Other net income (expense)
Income before tax 23.91%-7.35M7.31%-35.67M4.90%-7.56M16.01%-9.01M-2.58%-9.43M8.91%-9.66M13.23%-38.48M27.03%-7.95M1.13%-10.73M28.93%-9.2M
Income tax 0-34.59%-1.17M000-1.17M38.18%-869.17K0038.18%-869.17K
Net income 13.43%-7.35M8.28%-34.5M4.90%-7.56M16.01%-9.01M-13.28%-9.43M19.94%-8.49M12.42%-37.61M27.03%-7.95M1.13%-10.73M27.80%-8.33M
Net income continuous Operations 13.43%-7.35M8.28%-34.5M4.90%-7.56M16.01%-9.01M-13.28%-9.43M19.94%-8.49M12.42%-37.61M27.03%-7.95M1.13%-10.73M27.80%-8.33M
Minority interest income
Net income attributable to the parent company 13.43%-7.35M8.28%-34.5M4.90%-7.56M16.01%-9.01M-13.28%-9.43M19.94%-8.49M12.42%-37.61M27.03%-7.95M1.13%-10.73M27.80%-8.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 13.43%-7.35M8.28%-34.5M4.90%-7.56M16.01%-9.01M-13.28%-9.43M19.94%-8.49M12.42%-37.61M27.03%-7.95M1.13%-10.73M27.80%-8.33M
Basic earnings per share 38.10%-0.1328.16%-0.7433.33%-0.1434.48%-0.198.70%-0.2130.00%-0.2125.90%-1.0340.00%-0.2117.14%-0.2937.84%-0.23
Diluted earnings per share 38.10%-0.1328.16%-0.7433.33%-0.1434.48%-0.198.70%-0.2130.00%-0.2125.90%-1.0340.00%-0.2117.14%-0.2937.84%-0.23
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -